Lithium carbonate 300 mg Oral Tablet
RxNorm 197890
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 197890 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lithium carbonate 300 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Lithium carbonate 300 mg Oral Tablet
(Atom ID: 12324506)
SYPrescribable
Synonym (SY):
LiCO3 300 mg Oral Tablet
(Atom ID: 3854710)
PSNPrescribable
Prescribable Name (PSN):
Lithium carbonate 300 mg Oral Tablet
(Atom ID: 6358980)
PTPrescribable
Designated preferred name (PT):
Lithium carbonate 300 mg oral tablet
(Atom ID: 9251584)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely lithium carbonate 300 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10314345)
Patient Education
Lithium
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
[Learn More]
* Please review the disclaimer below.